Program
Celecoxib
Also written as “celecoxib”, “Celecoxib 200mg” and “Celecoxib + Acetaminophen”.
Its studies are mostly in Osteoarthritis · Osteoarthritis, Knee · Low Back Pain · Migraine Disorders · Pain, Postoperative, led by 16 companies.
Drug pageCelecoxib: every studyMany companies study it; this page follows only the 66 they lead. All 383 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Viatrisits history only | 320 open or running | phase 4since Aug 26, 2005 | Aug 26, 2005 | none ahead |
| Pfizerits history only | 100 open or running | phase 4since Sep 9, 2005 | May 8, 2002 | none ahead |
| Dr. Reddy's Laboratoriesits history only | 40 open or running | phase 2since Jun 8, 2015 | Jun 8, 2015 | none ahead |
| NeuroSense Therapeuticsits history only | 40 open or running | phase 2since Nov 13, 2019 | Aug 29, 2019 | none ahead |
| Leidos Life Sciencesits history only | 30 open or running | phase 2since Oct 7, 2021 | Oct 7, 2021 | none ahead |
| BioDelivery Sciences Internationalits history only | 20 open or running | phase 3since Dec 27, 2016 | Dec 27, 2016 | none ahead |
| Laboratorios Silanes S.A. de C.V.its history only | 20 open or running | phase 3since Jun 26, 2024 | Jun 26, 2024 | none ahead |
| Aralez Pharmaceuticalsits history only | 10 open or running | phase 1since Aug 5, 2008 | Aug 5, 2008 | none ahead |
| Arthritis Innovationits history only | 10 open or running | phase 2since May 8, 2018 | May 8, 2018 | none ahead |
| Astellas Pharmaits history only | 10 open or running | phase 3since May 5, 2010 | May 5, 2010 | none ahead |
| Bausch Health Companiesits history only | 10 open or running | phase 3since Jul 3, 2006 | Jul 3, 2006 | none ahead |
| Chong Kun Dang Pharmaceuticalits history only | 10 open or running | phase 4since Feb 3, 2017 | Feb 3, 2017 | none ahead |
| Dong-A STits history only | 10 open or running | phase 4since May 19, 2016 | May 19, 2016 | none ahead |
| Kitov Pharmaceuticalsits history only | 10 open or running | phase 3since Jun 20, 2014 | Jun 20, 2014 | none ahead |
| Mundipharmaits history only | 10 open or running | phase 3since Feb 20, 2017 | Feb 20, 2017 | none ahead |
| X-pert Medits history only | 10 open or running | phase 1since Nov 9, 2009 | Nov 9, 2009 | none ahead |
Also a collaborator on its studies: AstraZeneca.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of every company. Pick one to see its own:
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 43 studies since Aug 29, 2005.
- Dec 27, 2016BioDelivery Sciences International’s first studies: 2 phase 3 studies in Migraine DisordersNew to BioDelivery Sciences InternationalBioDelivery Sciences International · NCT03009019, NCT03006276
- Feb 3, 2017Chong Kun Dang Pharmaceutical’s first study: phase 4 study in Osteoarthritis HandNew to Chong Kun Dang PharmaceuticalChong Kun Dang Pharmaceutical · NCT03067194 · 117 enrolled · Korea, Republic of
- Feb 7, 2017Phase 1 study in HealthyDr. Reddy's Laboratories · NCT03051685 · 16 enrolled · United States
- Feb 20, 2017Mundipharma’s first study: phase 3 study in Acute PainNew to MundipharmaMundipharma · NCT03062644 · 1,138 enrolled · Belarus, Bulgaria, Canada and more
- Aug 17, 2017Phase 1 study in Migraine DisordersDr. Reddy's Laboratories · NCT03282838 · 24 enrolled · United States
- May 8, 2018Arthritis Innovation’s first study: phase 2 study in Pain, PostoperativeNew to Arthritis InnovationArthritis Innovation · NCT03541655 · 20 enrolled · United States
- May 21, 2018Phase 2 study in Acute PainDr. Reddy's Laboratories · NCT03554772 · 120 enrolled · United States
- Aug 29, 2019NeuroSense Therapeutics’ first study: phase 1 study in Amyotrophic Lateral SclerosisNew to NeuroSense TherapeuticsNeuroSense Therapeutics · NCT04090684 · 10 enrolled · United States
- Nov 13, 2019Phase 2 study in Amyotrophic Lateral SclerosisNeuroSense Therapeutics · NCT04165850 · 16 enrolled · Israel
- Oct 7, 2021Leidos Life Sciences’ first studies: 3 phase 2 studies in COVID-19New to Leidos Life SciencesLeidos Life Sciences · NCT05085574, NCT05077969, NCT05077332
- Jan 19, 2022Phase 1 study in PharmacokineticsNeuroSense Therapeutics · NCT05232461 · 12 enrolled · United States
- Jun 22, 2022Phase 1 study in PharmacokineticsNeuroSense Therapeutics · NCT05436678 · 19 enrolled · United States
- Jun 26, 2024Laboratorios Silanes S.A. de C.V.’s first study: phase 3 study in Low Back PainNew to Laboratorios Silanes S.A. de C.V.Laboratorios Silanes S.A. de C.V. · NCT06516094 · 192 enrolled · Mexico
- Mar 3, 2025Phase 3 study in ArthralgiaLaboratorios Silanes S.A. de C.V. · NCT06863636 · 231 enrolled · Mexico
TargetBeta
“Cyclooxygenase-2 inhibitor”ChEMBL 37, by rule
Other programs on PTGS2
| Program | Company | Furthest phase | Studies |
|---|---|---|---|
| Acetaminophenrule | Johnson & Johnson | phase 4 | 136 |
| Ibuprofenrule | Pfizer | phase 4 | 113 |
| Aspirinrule | Bayer | phase 4 | 84 |
| Meloxicamrule | Boehringer Ingelheim | phase 4 | 67 |
| Etoricoxibrule | Organon | phase 4 | 35 |
| dexketoprofenrule | Menarini Group | phase 4 | 8 |
| Sulfasalazinerule | Bristol-Myers Squibb | phase 4 | 7 |
| dexibuprofenrule | aponia-laboratories-inc | phase 4 | 6 |
| Benzydaminerule | Angelini Pharma | phase 4 | 4 |
| Dipyronerule | Hypera Pharma | phase 4 | 4 |
| Piroxicamrule | Taisho Pharmaceutical | phase 4 | 4 |
| Flurbiprofenrule | GlaxoSmithKline | phase 3 | 12 |
Studies
The newest 60 of 66 led by companies developing it. Each opens its study page. Every study on its drug page →
| Study | Phase | Status | Led by | Primary completion | Size |
|---|---|---|---|---|---|
| NCT06863636Arthralgia · Mexico | 3 | Completed | Laboratorios Silanes S.A. de C.V. | Oct 30, 2025 | 231 |
| NCT06516094Low Back Pain · Mexico | 3 | Completed | Laboratorios Silanes S.A. de C.V. | Jan 1, 2025 | 192 |
| NCT05436678Pharmacokinetics · United States | 1 | Completed | NeuroSense Therapeutics | Aug 19, 2022 | 19 |
| NCT05232461Pharmacokinetics · United States | 1 | Completed | NeuroSense Therapeutics | Apr 21, 2022 | 12 |
| NCT05085574COVID-19 | 2 | Withdrawn | Leidos Life Sciences | Feb 7, 2023 | 0 |
| NCT05077969COVID-19 · United States | 2 | Terminated | Leidos Life Sciences | Jun 28, 2022 | 4 |
| NCT05077332COVID-19 · United States | 2 | Completed | Leidos Life Sciences | Nov 10, 2025 | 4 |
| NCT04165850Amyotrophic Lateral Sclerosis · Israel | 2 | Completed | NeuroSense Therapeutics | Jan 19, 2021 | 16 |
| NCT04090684Amyotrophic Lateral Sclerosis · United States | 1 | Completed | NeuroSense Therapeutics | Sep 27, 2021 | 10 |
| NCT03554772Acute Pain · United States | 2 | Completed | Dr. Reddy's Laboratories | Aug 20, 2018 | 120 |
| NCT03541655Pain, Postoperative · United States | 2 | Completed | Arthritis Innovation | Jun 20, 2019 | 20 |
| NCT03282838Migraine Disorders · United States | 1 | Completed | Dr. Reddy's Laboratories | Aug 22, 2017 | 24 |
| NCT03062644Acute Pain · Belarus, Bulgaria, Canada and more | 3 | Completed | Mundipharma | Jun 29, 2018 | 1,138 |
| NCT03051685Healthy · United States | 1 | Completed | Dr. Reddy's Laboratories | Aug 14, 2015 | 16 |
| NCT03067194Osteoarthritis Hand · Korea, Republic of | 4 | Completed | Chong Kun Dang Pharmaceutical | Jul 10, 2017 | 117 |
| NCT03009019Migraine Disorders · United States | 3 | Completed | BioDelivery Sciences International | Nov 2017 | 631 |
| NCT03006276Migraine Disorders · United States | 3 | Completed | BioDelivery Sciences International | Nov 2017 | 622 |
| NCT02780323Arthritis, Rheumatoid · Korea, Republic of | 4 | Completed | Dong-A ST | Dec 26, 2017 | 119 |
| NCT02472418Migraine Disorders · United States | 2 | Completed | Dr. Reddy's Laboratories | Dec 1, 2015 | 63 |
| NCT02172040Hypertension · United Kingdom | 3 | Completed | Kitov Pharmaceuticals | Nov 19, 2015 | 152 |
| NCT01838044Chronic Low Back Pain With a Neuropathic Component · Brazil, Chile, Colombia and more | 4 | Terminated | Viatris | May 2015 | 180 |
| NCT01118572Pain, Postoperative · Japan | 3 | Completed | Astellas Pharma | Nov 2010 | 616 |
| NCT01062113Pain · Japan | 2 | Completed | Viatris | Aug 2010 | 255 |
| NCT01020279Musculoskeletal Pain · Germany | 1 | Completed | X-pert Med | 82 | |
| NCT00994461Healthy Volunteers · Japan | 4 | Completed | Viatris | Apr 2010 | 190 |
| NCT00976716Pain · Japan | 3 | Completed | Viatris | Nov 2009 | 80 |
| NCT00894790Pain · Mexico | 4 | Terminated | Viatris | Jan 2010 | 8 |
| NCT00807846Arthritis, Juvenile · United States, Chile, Costa Rica and more | 4 | Completed | Viatris | Dec 2012 | 201 |
| NCT00762463Spondylitis, Ankylosing · China | 3 | Completed | Viatris | Jun 2010 | 240 |
| NCT00729495Healthy Volunteer · United States | 1 | Completed | Aralez Pharmaceuticals | Aug 2008 | 80 |
| NCT00663767Toothache · United States | 2 | Completed | Pfizer | Jun 20, 2008 | 250 |
| NCT00652925Arthritis, Juvenile · United States, Belgium, Brazil and more | 3 | Completed | Pfizer | Apr 2004 | 225 |
| NCT00648141Spondylitis, Ankylosing · Germany | 3 | Completed | Pfizer | 458 | |
| NCT00643799Osteoarthritis, Knee · United States | 4 | Completed | Viatris | Jan 2005 | 586 |
| NCT00640809Inflammatory Bowel Diseases · United States | 4 | Completed | Viatris | 408 | |
| NCT00640627Osteoarthritis, Knee · United States | 4 | Completed | Viatris | 380 | |
| NCT00640432Low Back Pain · Brazil | 4 | Completed | Viatris | 244 | |
| NCT00639483Schizophrenia · Argentina, Brazil, Germany and more | 2 | Completed | Pfizer | 270 | |
| NCT00638807Osteoarthritis, Knee · United States | 4 | Completed | Viatris | 388 | |
| NCT00633438Arthroscopy · United States | 4 | Completed | Viatris | 204 | |
| NCT00633386Arthroscopy · United States | 4 | Completed | Viatris | 200 | |
| NCT00630929Osteoarthritis, Knee · Germany, Spain, United Kingdom | 4 | Completed | Viatris | 388 | |
| NCT00620867Osteoarthritis, Knee · United States | 4 | Completed | Viatris | Mar 2003 | 393 |
| NCT00585312Adenomatous Polyposis Coli · United States, Belgium, Czechia and more | 3 | Terminated | Viatris | Oct 2013 | 106 |
| NCT00662558Low Back Pain · United States | 3 | Completed | Viatris | Sep 2008 | 802 |
| NCT00549549Arthritis, Gouty · United States, Canada, Colombia and more | 3 | Completed | Viatris | Dec 2009 | 402 |
| NCT00484718Osteoarthritis · United States | 4 | Terminated | Pfizer | Jun 10, 2009 | 6 |
| NCT00446797Ankle Injuries · Brazil, Costa Rica, Ecuador and more | 4 | Completed | Viatris | Apr 2008 | 278 |
| NCT00402987Pharyngitis · United States | 3 | Completed | Viatris | Nov 15, 2007 | 269 |
| NCT00373685Osteoarthritis · United States, Puerto Rico | 4 | Completed | Viatris | Nov 2010 | 8,067 |
| NCT00359151Osteoarthritis · United States | 4 | Terminated | Viatris | 22 | |
| NCT00348452Chronic Pain | 3 | Completed | Bausch Health Companies | 1,000 | |
| NCT00346216Arthritis, Rheumatoid · United States, Australia, Brazil and more | 4 | Completed | Viatris | Apr 12, 2016 | 24,081 |
| NCT00296127Healthy Volunteers · United States | 1 | Completed | Viatris | 24 | |
| NCT00290901Back Pain · United States, Puerto Rico | 4 | Completed | Viatris | Dec 2006 | 754 |
| NCT00174317Osteoarthritis, Hip · United Kingdom | 4 | Completed | Pfizer | 250 | |
| NCT00163241Osteoarthritis · Canada, France | 3 | Terminated | Viatris | 666 | |
| NCT00150280Pain, Postoperative · China | 3 | Completed | Viatris | 132 | |
| NCT00141154Low Back Pain · Japan | 3 | Completed | Viatris | 1,234 | |
| NCT00141102Osteoarthritis · Belgium, Brazil, Canada and more | 4 | Completed | Viatris | May 2009 | 4,484 |
How it is read
Names in the registry
- “Celecoxib”, 49 entries
- “celecoxib”, 7 entries
- “Celecoxib 200mg”, 3 entries
- “Celecoxib + Acetaminophen”, 2 entries
- “Comparator: celecoxib”, 2 entries
Codes read as this program: DFN15.
Conditions, from the studies’ own filings
- Osteoarthritis, 8 studies
- Osteoarthritis, Knee, 8 studies
- Low Back Pain, 5 studies
- Migraine Disorders, 4 studies
- Pain, Postoperative, 4 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.